Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)

Nath Bio-Genes (India) Statistics

Total Valuation

NSE:NATHBIOGEN has a market cap or net worth of INR 3.17 billion. The enterprise value is 3.51 billion.

Market Cap	3.17B
Enterprise Value	3.51B

Important Dates

The next estimated earnings date is Friday, October 10, 2025.

Earnings Date	Oct 10, 2025
Ex-Dividend Date	Aug 14, 2025

Share Statistics

NSE:NATHBIOGEN has 19.00 million shares outstanding. The number of shares has increased by 0.11% in one year.

Current Share Class	19.00M
Shares Outstanding	19.00M
Shares Change (YoY)	+0.11%
Shares Change (QoQ)	+46.56%
Owned by Insiders (%)	11.01%
Owned by Institutions (%)	2.23%
Float	5.90M

Valuation Ratios

The trailing PE ratio is 7.96.

PE Ratio	7.96
Forward PE	n/a
PS Ratio	0.78
PB Ratio	0.49
P/TBV Ratio	0.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	8.25
EV / Sales	0.87
EV / EBITDA	6.81
EV / EBIT	7.37
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.19
Debt / EBITDA	2.38
Debt / FCF	n/a
Interest Coverage	4.16

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	4.00%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	8.97M
Profits Per Employee	942,927
Employee Count	451
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:NATHBIOGEN has paid 23.99 million in taxes.

Income Tax	23.99M
Effective Tax Rate	5.67%

Stock Price Statistics

The stock price has decreased by -24.40% in the last 52 weeks. The beta is 0.47, so NSE:NATHBIOGEN's price volatility has been lower than the market average.

Beta (5Y)	0.47
52-Week Price Change	-24.40%
50-Day Moving Average	181.49
200-Day Moving Average	178.10
Relative Strength Index (RSI)	35.10
Average Volume (20 Days)	12,366

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:NATHBIOGEN had revenue of INR 4.05 billion and earned 425.26 million in profits. Earnings per share was 22.33.

Revenue	4.05B
Gross Profit	2.52B
Operating Income	475.80M
Pretax Income	423.21M
Net Income	425.26M
EBITDA	515.37M
EBIT	475.80M
Earnings Per Share (EPS)	22.33

Balance Sheet

The company has 888.99 million in cash and 1.23 billion in debt, giving a net cash position of -336.01 million or -17.68 per share.

Cash & Cash Equivalents	888.99M
Total Debt	1.23B
Net Cash	-336.01M
Net Cash Per Share	-17.68
Equity (Book Value)	6.44B
Book Value Per Share	496.02
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 62.33%, with operating and profit margins of 11.76% and 10.51%.

Gross Margin	62.33%
Operating Margin	11.76%
Pretax Margin	10.46%
Profit Margin	10.51%
EBITDA Margin	12.73%
EBIT Margin	11.76%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 1.20%.

Dividend Per Share	2.00
Dividend Yield	1.20%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.11%
Shareholder Yield	1.09%
Earnings Yield	13.41%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1